Health professionals are
advised by the Therapeutic Goods
Administration of a short supply
of ovulatory failure treatment
clomifene 50mg tablets (previously
spelt clomiphene) marketed in
Australia as Clomid (Sanofi Aventis)
and Serophene (Merck Serono).
Clomid’s shortage is due to
manufacturing issues, and should
come back on line 31 Dec 2016
while Serophene will be out-of-stock
by end of possibly later
this week 2016 due to technical
manufacturing issues.
The TGA advises it has granted a
section 19A approval for the import
and supply of an alternative French
product Clomid (clomifene citrate)
50 mg tablets.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 16
THOUGH women make up 60% of pharmacy graduates and pharmacists, they hold only 34% of leadership and ownership roles, according to Andria Aird, a community pharmacist, pharmacy owner, and Board Director of Blooms The Chemist.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.